2025-2026 Eye Care Device & Eye Massager Industry
In-Depth Intelligence Report
Executive Summary — The household eye care instrument sector in China is experiencing explosive growth during 2025-2026, with eye massagers and therapeutic eye instruments emerging as a blue ocean within consumer health electronics.
Market size is projected to surpass RMB 11.9 billion (approx. US$1.64B) in 2026, recording over 21% CAGR. Domestic brands are gaining significant share, while online channels dominate distribution.
Technology upgrades (AI massage, Bluetooth-enabled smart control, nano-hot compress) reshape product value. Intelligence, compliance, and pediatric-specific solutions become the mainstream trajectory.
I. Market Size & Growth Trajectory
Driven by rising awareness of eye health, surging “screen time” population, and continuous product innovation, the eye massager + therapeutic eye instrument market reached RMB 9.9 billion in 2025, a 20% year-on-year increase.
Forecasts indicate the market will hit RMB 11.9 billion in 2026, representing a robust 22% growth — outpacing many personal care sub-sectors. Industry penetration remains at an early stage, with vast untapped potential.
| Year | Market Size (RMB Billion) | YoY Growth (%) |
|---|
| 2025 (Actual) | 9.9 | 20% |
| 2026 (Forecast) | 11.9 | 22% |
II. Core Drivers & Competitive Landscape Evolution
2.1 Key Market Drivers
- Massive demand for eye relief: Over 700 million myopic population in China; office workers face >10 hours of daily screen exposure, leading to surging dry eye and visual fatigue.
- Technological breakthroughs: AI-driven air pressure massage, dual hot/cold compress, and intelligent acupoint recognition significantly improve efficacy.
- Regulatory push for standardization: The “General Technical Specifications for Household Eye Care Devices” (2025) eliminates substandard products, benefiting leading brands.
- E-commerce dominance: Livestreaming and content marketing accelerate category adoption; online channels captured 75% of sales in 2025 (Tmall, Douyin).
- Domestic brand ascendance: Chinese brands leverage agile supply chains, localized algorithms, and value pricing, raising market share from 52% (2024) to 62% (2025).
| Channel | 2025 Sales Share (%) |
|---|
| Online (E-comm + livestream) | 75% |
| Offline (Retail/Pharmacy/Experience) | 25% |
| Brand Origin | 2024 Market Share (%) | 2025 Market Share (%) |
|---|
| Chinese Domestic Brands (Breo, SKG, Bear, etc.) | 52% | 62% |
| International Brands (Panasonic, Philips, etc.) | 48% | 38% |
2.2 Price Tier Structural Shift
The market shows clear consumption polarization. Mid-range (RMB 400-900 / ~US$55-125) becomes the absolute mainstream with 47% share due to balanced performance and value. Premium segment (above RMB 900) holds 38% driven by cutting-edge tech and brand power. Low-end entry-level products shrink to 15%. A similar trend is observed in therapeutic eye instruments, underscoring the quality upgrade.
| Price Tier | Eye Massager Share (%) |
|---|
| Premium (≥900 RMB) | 38% |
| Mid-Range (400-899 RMB) | 47% |
| Entry-Level (<400 RMB) | 15% |
| Price Tier | Therapeutic Eye Instrument Share (%) |
|---|
| Premium | 40% |
| Mid-Range | 48% |
| Entry-Level | 12% |
2.3 Pain Points & Future Trends
Core Pain Points: Exaggerated efficacy claims, severe product homogenization (similar design/features), uneven consumer awareness, lack of medical-grade validation.
Over the next two years, the industry will evolve toward “AI-personalized recommendations + health data interoperability,” with pediatric eye care emerging as a key growth pole.
| Pain Point Category | User Mention Rate (%) |
|---|
| Exaggerated efficacy claims | 32% |
| Product homogenization | 28% |
| Low consumer awareness | 20% |
| Minor technological differentiation | 12% |
| Poor facial fit adaptability | 8% |
| Future Trend | Industry Attention (%) |
|---|
| Intelligence (AI / APP connectivity) | 85% |
| Precision (zoned massage) | 78% |
| Portability & foldable design | 72% |
| Medical-device compliance | 82% |
| Health ecosystem synergy | 68% |
| Pediatric vision care solutions | 75% |
III. Best-Selling Products: Core Selling Points & Efficacy Comparison
Leading brands differentiate through eye fatigue relief rates, dark circle improvement percentages, and blue-light filtering technology. Breo, SKG, and Panasonic flagship models excel, while lightweight materials become a decisive purchase factor.
| Brand | Eye Fatigue Relief (Self-reported %) | Dark Circle Improvement (%) |
|---|
| Breo | 90% | 82% |
| SKG | 85% | 75% |
| Bear | 78% | 65% |
| Panasonic | 88% | 78% |
| Rongtai | 80% | 70% |
| Product Model | Blue-Light Filter Rate (%) | Device Weight (g) |
|---|
| Breo F3 | 90% | 92g |
| SKG B3 | 88% | 95g |
| Bear E01 | 80% | 100g |
| Philips EyeCare Series | 92% | 88g |
※ Blue-light filter rate relates to lens/optical technology in eye instruments; lightweight enhances wear comfort.
IV. SWOT Quantitative Analysis
Based on expert scoring and consumer surveys, strengths (product awareness, growth engine) and opportunities (pediatric market, smart health ecosystems) outweigh threats. Nevertheless, intensifying competition and stricter regulations require vigilance.
| Strength Factor | Weight Score (100) |
|---|
| Intrinsic eye-care positioning | 85 |
| Market growth potential | 90 |
| Domestic supply chain competitiveness | 82 |
| Mature online channel infrastructure | 78 |
| Improved compliance & standards | 75 |
| Opportunity Factor | Potential Score |
|---|
| Premium demand for eye wellness | 90 |
| Technology convergence (AR/neuro-sensing) | 88 |
| Channel expansion to lower-tier cities | 85 |
| Government health promotion policies | 78 |
| Cross-brand/IP collaborations | 75 |
| Myopia prevention for children/teens | 92 |
| Threat Factor | Risk Index |
|---|
| Intense competition (new entrants) | 85 |
| Stricter regulation / false advertising penalties | 80 |
| Alternative products (eye patches, sprays) | 70 |
| Consumer trust crisis | 75 |
| Fast technological obsolescence pressure | 82 |
V. 4P Sales Strategy & Product Portfolio Recommendations
In 2026, brands should focus on a “tech + professional” dual strategy: premium models emphasize AI physiotherapy credentials; mid-range best-sellers balance value and aesthetics; entry-level products act as lightweight traffic drivers. According to forecasts, mid-range eye massagers will account for 60% of volume sales, while therapeutic eye instruments will see 63% mid-range share, with premium segment steadily expanding.
| Product Category | Premium Volume Share (%) | Mid-Range Volume Share (%) | Entry-Level Share (%) |
|---|
| Eye Massager | 25% | 60% | 15% |
| Therapeutic Eye Instrument (hot/cold) | 22% | 63% | 15% |
Data integrated from 2025-2026 e-commerce platform reports, enterprise financial disclosures, and consumer insights. Forecast based on compounded growth trends.
This report is for professional reference only and does not constitute investment advice.
